Induction of leukotriene B4 and prostaglandin E2 release from keratinocytes by protease-activated receptor-2-activating peptide in ICR mice

International Immunopharmacology

Volumn 9, Issue 11, 2009, Pages 1332-1336

  Zhu, Yu ^a   Wang, Xiao Rong ^a   Peng, Cheng ^a   Xu, Jian Guo ^a   Liu, Yan Xia ^a   Wu, Liang ^a   Zhu, Quan Gang ^a   Liu, Ji Yong ^a   Li, Feng Qian ^a   Pan, Yong Hua ^a   You, Ben Ming ^a   Hu, Jin Hong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Keratinocyte; Leukotriene B4; PAR2; Prostaglandin E2; Tacrolimus

Indexed keywords

CETIRIZINE; INDOMETACIN; LEUKOTRIENE B4; PROSTAGLANDIN E2; PROTEINASE ACTIVATED RECEPTOR 2; TACROLIMUS; ZILEUTON;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; INCUBATION TIME; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SCRATCHING;

ANIMALS; CETIRIZINE; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HYDROXYUREA; INDOMETHACIN; INJECTIONS, INTRADERMAL; KERATINOCYTES; LEUKOTRIENE B4; MALE; MICE; MICE, INBRED ICR; OLIGOPEPTIDES; PRURITUS; SKIN; TACROLIMUS;

EID: 70249103828     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.08.006     Document Type: Article

References (36)

1. Steinhoff M., Buddenkotte J., Shpacovitch V., Rattenholl A., Moormann C., Vergnolle N., et al. Protease-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 26 (2005) 1-43
2. Barry G.D., Le G.T., and Fairlie D.P. Agonists and antagonists of protease activated receptors (PARs). Curr Med Chem 13 (2006) 243-265
3. Steinhoff M., Vergnolle N., Young S.H., Tognetto M., Amadesi S., Ennes H.S., et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6 (2000) 151-158
4. Ossovskaya V.S., and Bunnett N.W. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84 (2004) 579-621
5. Shpacovitch V., Feld M., Bunnett N.W., and Steinhoff M. Protease-activated receptors: novel PARtners in innate immunity. Trends Immunol 28 (2007) 541-550
6. Hou L., Kapas S., Cruchley A.T., Macey M.G., Harriott P., Chinni C., et al. Immunolocalization of protease-activated receptor-2 in skin: receptor activation stimulates interleukin-8 secretion by keratinocytes in vitro. Immunology 94 (1998) 356-362
7. Steinhoff M., Corvera C.U., Thoma M.S., Kong W., McAlpine B.E., Caughey G.H., et al. Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 8 (1999) 282-294
8. Steinhoff M., Neisius U., Ikoma A., Fartasch M., Heyer G., Skov P.S., et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 23 (2003) 6176-6180
9. 2. Eur J Pharmacol 530 (2006) 281-283
10. Brain S., Camp R., Dowd P., Black A.K., and Greaves M. The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J Invest Dermatol 83 (1984) 70-73
11. Ruzicka T., Simmet T., Peskar B.A., and Ring J. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol 86 (1986) 105-108
12. 2, induces itch-associated responses in mice. Eur J Pharmacol 353 (1998) 93-96
13. 4 in substance P-induced itch-associated response in mice. J Invest Dermatol 117 (2001) 1621-1626
14. 4 in mice. J Invest Dermatol 123 (2004) 196-201
15. 2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. J Am Acad Dermatol 47 (2002) 28-32
16. Greaves M.V., and Wall P.D. Pathophysiology of itching. Lancet 348 (1996) 938-940
17. Steinhoff M., Bienenstock J., Schmelz M., Maurer M., Wei E., and Bíró T. Neurophysiological, neuroimmunological and neuroendocrine basis of pruritus. J Invest Dermatol 126 (2006) 1705-1718
18. Ruzicka T., Bieber T., Schöpf E., Rubins A., Dobozy A., Bos J.D., et al. A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med 337 (1997) 816-821
19. Boguniewicz M., Fiedler V.C., Raimer S., Lawrence I.D., Leung D.Y., and Hanifin J.M. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. J Allergy Clin Immunol 102 (1998) 637-644
20. Tawfik O.W., Huet Y.M., Malathy P.V., Johnson D.C., and Dey S.K. Release of prostaglandins and leukotrienes from the rat uterus is an early estrogenic response. Prostaglandins 34 (1987) 805-815
21. Urien S., Tillement J.P., Ganem B., and Kuch M.D. A pharmacokinetic pharmacodynamic modelling of the antihistaminic (H1) effects of cetirizine. Int J Clin Pharmacol Ther 37 (1999) 499-502
22. Awni W.M., Braeckman R.A., Granneman G.R., Witt G., and Dubé L.M. Pharmacokinetics and pharmacodynamics of zileuton after oral administration of single and multiple dose regimens of zileuton 600 mg in healthy volunteers. Clin Pharmacokinet 29 Suppl 2 (1995) 22-33
23. Emori H.W., Paulus H., Bluestone R., Champion G.D., and Pearson C. Indomethacin serum concentrations in man. Effects of dosage, food, and antacid. Ann Rheum Dis 35 (1976) 333-338
24. Kuraishi Y., Nagasawa T., Hayashi K., and Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol 275 (1995) 229-233
25. 4 receptor on the dorsal root ganglion neurons in mice. Mol Brain Res 137 (2005) 263-266
26. Ständer S., Weisshaar E., and Luger T.A. Neurophysiological and neurochemical basis of modern pruritus treatment. Exp Dermatol 17 (2008) 161-169
27. Schmelz M., Schmidt R., Bickel A., Handwerker H.O., and Torebjork H.E. Specific C-receptors for itch in human skin. J Neurosci 17 (1997) 8003-8008
28. 2 and a prostaglandin endoperoxide analog. J Invest Dermatol 69 (1977) 527-530
29. 2 sensitizes primary sensory neurons to histamine. Neuroscience 150 (2007) 22-30
30. 1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. Eur J Pharmacol 505 (2004) 229-235
31. 2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice. Eur J Pharmacol 518 (2005) 56-62
32. Cheer S.M., and Plosker GL. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis. Am J Clin Dermatol 2 (2001) 389-406
33. Inagaki N., Shiraishi N., Igeta K., Itoh T., Chikumoto T., Nagao M., et al. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone. Eur J Pharmacol 546 (2006) 189-196
34. Nakano T., Andoh T., Tayama M., Kosaka M., Lee J.B., and Kuraishi Y. Effects of topical application of tacrolimus on acute itch-associated responses in mice. Biol Pharm Bull 31 (2008) 752-754
35. Moormann C., Artuc M., Pohl E., Varga G., Buddenkotte J., Vergnolle N., et al. Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells. J Invest Dermatol 126 (2006) 746-755
36. Seeliger S., Derian C., Vergnolle N., Bunnett N.W., Nawroth R., Schmelz M., et al. Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. FASEB J 17 (2003) 1871-1885